Last updated on April 2017

A Local Clinical Study for the Comparative Evaluation of Efficacy and Safety of Angal Lozenges [Menthol] and ANTI-ANGIN FORMULA Lozenges in Treatment of Patients With a Sore Throat

Brief description of study

The purpose of this study is to evaluate no less therapeutic efficacy and safety of the Angal, lozenges [Menthol], 1 mg + 5 mg (Sandoz dd, Slovenia) compared to ANTI-ANGIN® FORMULA, lozenges, 0,2 mg + 2 mg + 50 mg (LLC "Valeant", Russia) in treatment of patients with uncomplicated acute infectious and inflammatory diseases of the pharynx, accompanied by a sore throat.

Clinical Study Identifier: NCT03095521

Contact Investigators or Research Sites near you

Start Over


Sandoz Investigational Site
Moscow, Russian Federation
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.